News & Perspective

Feb 29, 2008

Feb 29, 2008

Judge dismisses suit to limit DoD anthrax vaccinations

(CIDRAP News) – A federal district judge has dismissed a lawsuit aiming to stop the Pentagon's mandatory anthrax vaccination program for troops serving in some areas overseas, the Associated Press (AP) reported today.

Judge Rosemary M. Collyer in Washington, DC, said the Food and Drug Administration (FDA) acted appropriately when it determined the vaccine was safe and approved its use, according to the AP.

Mar 07, 2008

Mar 07, 2008

CDC retires one old smallpox vaccine, keeps another

(CIDRAP News) – Federal health officials recently announced plans to get rid of their last remaining stocks of the decades-old smallpox vaccine Dryvax, as a newer vaccine takes its place in the national stockpile of emergency medical supplies.

Apr 08, 2008

Apr 08, 2008

DoD funds development of anthrax vaccine patch

(CIDRAP News) – Iomai Corp., a biotechnology company that specializes in needle-free vaccines, announced today that it will receive a grant from the US Department of Defense (DoD) to fund preclinical development of a patch-based anthrax vaccine.

The 1-year grant to Iomai, based in Gaithersburg, Md., will be in the form of a $943,856 cost reimbursement from the US Army Medical Research and Material Command, according to a press release from Iomai.

May 02, 2008

May 02, 2008

Researchers find fast way to make human antibodies against flu

(CIDRAP News) – Technical barriers have prevented the widespread use of human monoclonal antibodies as potent diagnostic and treatment tools, but scientists now say they have found a way to produce antibodies against seasonal influenza much faster than was previously possible.

May 07, 2008

May 07, 2008

VaxGen sells anthrax vaccine to rival firm

(CIDRAP News) – VaxGen Inc. announced this week the sale of its experimental anthrax vaccine—which the US government pulled the plug on in 2006—to Emergent BioSolutions, maker of the only US-licensed anthrax vaccine.

May 20, 2008

May 20, 2008

FDA approves levofloxacin for anthrax in children

(CIDRAP News) – The US Food and Drug Administration (FDA) recently offered another antibiotic option for combating inhalational anthrax in children by approving the quinolone drug levofloxacin (Levaquin).

In a letter dated May 5, the FDA endorsed the use of levofloxacin, made by Ortho-McNeil, in children 6 months of age and older. The agency had approved use of the drug for postexposure treatment of anthrax in adults in 2004.

Jun 03, 2008

Jun 03, 2008

HHS announces preparedness grants for public health, hospitals

(CIDRAP News) – The US Department of Health and Human Services (HHS) today announced that it is allocating states and major metropolitan areas $1.1 billion to strengthen public health preparedness and help healthcare facilities respond to emergency events such as an influenza pandemic or terrorist attack.

Jul 22, 2008

Jul 22, 2008

DHS aims for faster detection of airborne pathogens

(CIDRAP News) – The Department of Homeland Security (DHS) plans to adopt new automated equipment that will be able to detect dangerous airborne pathogens in major US cities in as little as 4 hours, with a goal of starting deployment in the fall of 2010, DHS officials told Congress last week.

Jul 24, 2008

Jul 24, 2008

BioWatch demands on state labs called burdensome

(CIDRAP News) – The president of the Association of Public Health Laboratories (APHL) complained to Congress last week that the federal program that monitors the air for dangerous pathogens in major cities is a heavy burden on state and local laboratories.

Jul 29, 2008

Jul 29, 2008

Anthrax vaccine maker wins NIAID grants

(CIDRAP News) – Emergent BioSolutions Inc. recently announced it had secured two federal grants totaling $4.5 million for development of its botulism and next-generation anthrax vaccine candidates.

Emergent, maker of the nation's only licensed anthrax vaccine, announced the grants from the National Institute of Allergy and Infectious Diseases (NIAID) in a Jul 24 news release.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»